Metabolism of free fatty acids（FFAs） is related to several important physiological events and therefore their quantitaion in biological samples arouses extensive interest and efforts.Existing gas chromatography with...Metabolism of free fatty acids（FFAs） is related to several important physiological events and therefore their quantitaion in biological samples arouses extensive interest and efforts.Existing gas chromatography with flame ionization detector（GC-FID） methods for the analysis of FFAs normally require derivatization of them in order to lower boiling points.But this extra procedure tends to induce additional error and it is laborious and time-consuming.A derivatization-free method was therefore established in the present investigation to determine FFAs in human plasma by capillary（GC-FID）.After extraction of FFAs from plasma,a highly polar FFAP（free fatty acid in plasma） column was employed to directly quantitate FFAs concentration,free from derivatization reaction.All sample pretreatments were carried out at room temperature,improving recovery of short-chain FFAs.Heptadecanoic acid（C17：0） was employed as internal standard,and the proposed method was validated for recovery,precision,sensitivity,stabi-lity,and linearity.Validation data show that it is suitable for clinical study that has been applied to the evaluation of FFAs levels in plasma of diabetic nephropathy（DN） patients during the course of treatment.Forty-seven patients diagnosed with DN were admitted to the double-blind experiment.Control group（n=17） underwent solely basic treatment and the patients did not show significant change in FFAs concentration during six months of treatment.Experiment group（n=30） was supplied with traditional Chinese medicine besides basic treatment.After six months of medication,their plasma concentration of palmitic acid（C16：0）,stearic acid（C18：0） and oleic acid（C18：1n-9） decreased while linolenic acid（C18：3n-3） increased significantly（P〈0.05）.These four compounds could be served as biomar-kers in the evaluation of drug efficacy,and their quantitation in plasma may provide additional information for disease progression in DN patients.展开更多
Objective To investigate the therapeutic effect of intensive glycemic control on patients with early diabetic nephropathy. Methods A total of 41 type 2 diabetes patients who developed microalbuminuria were divided int...Objective To investigate the therapeutic effect of intensive glycemic control on patients with early diabetic nephropathy. Methods A total of 41 type 2 diabetes patients who developed microalbuminuria were divided into two groups randomly. Patients in Group A received intensive glycemic control and the blood glucose in Group B was regularly controlled. Glycemic monitoring and control were followed for 12 weeks to observe the changes of microalbuminuria in both groups; meanwhile the levels of serum lipids and coagulation indices were also recorded. Results The urine albumin excretion rate (UAER) in Group A decreased significantly from (47.91±13.86)mg/24h to (35.31±14.56)mg/24h after 12 weeks (P<0.05),and this decrease was significantly greater than that in Group B. However,Group B had no significant difference in UAER decrease [(48.93±13.32)mg/24h to (40.48±19.62)mg/24h,P>0.05]. The decrease of triglyceride (TG) and low-density lipoprotein cholesterol (LDL cholesterol),and the increase of high-density lipoprotein cholesterol (HDL cholesterol) showed no significant differences (P>0.05). And the level of plasma fibrinogen (FIB) showed no significant decrease after 12 weeks,either (P>0.05). Conclusion Intensive glycemic control reduces the level of microalbuminuria and may ameliorate the progression of early diabetic nephropathy.展开更多
【目的】观察苦瓜皂苷G对糖尿病肾病(DN)大鼠的治疗作用及机制。【方法】从55只大鼠中随机抽取45只采用一次性腹腔注射链脲佐菌素(STZ)法诱导DN模型。将造模成功的38只大鼠随机分为模型组9只、苦瓜皂苷G低剂量组9只、苦瓜皂苷G中剂量组1...【目的】观察苦瓜皂苷G对糖尿病肾病(DN)大鼠的治疗作用及机制。【方法】从55只大鼠中随机抽取45只采用一次性腹腔注射链脲佐菌素(STZ)法诱导DN模型。将造模成功的38只大鼠随机分为模型组9只、苦瓜皂苷G低剂量组9只、苦瓜皂苷G中剂量组10只、苦瓜皂苷G高剂量组10只。剩余10只大鼠设为正常组。对应灌胃给药4周后,酶联免疫吸附分析(ELISA)检测大鼠24 h尿蛋白水平,血糖仪检测空腹血糖(FBG),全自动生化分析仪检测血肌酐(SCr)、血尿素氮(BUN)水平,苏木素-伊红染色(HE)法观察大鼠肾组织病理学变化,采用实时定量聚合酶链反应(RT-qPCR)和Western Blot法分别检测E-钙黏蛋白(E-cad)、α-平滑肌肌动蛋白(α-SMA)、Notch1、锌指蛋白转录因子1(Snail1)、Jagged1 m RNA及蛋白表达情况。【结果】与正常组比较,模型组24 h尿蛋白、FBG、血清SCr和BUN水平及肾组织α-SMA、Notch1、Snail1、Jagged1 mRNA及蛋白水平显著升高,肾组织E-cad m RNA及蛋白水平降低,肾组织可见肾小球萎缩、肾小管扩张及间质纤维化;与模型组比较,苦瓜皂苷G低、中、高剂量组24 h尿蛋白、FBG、血清SCr和BUN水平及肾组织α-SMA、Notch1、Snail1、Jagged1 mRNA及蛋白水平显著降低,肾组织E-cad m RNA及蛋白水平升高,肾组织病理损伤得到改善。【结论】苦瓜皂苷G可有效改善DN大鼠肾功能障碍、减轻肾脏纤维化,其机制可能与通过调控Notch/Snail1信号通路,抑制α-SMA和Jagged1 mRNA及蛋白表达,增强E-cad mRNA及蛋白表达有关。展开更多
基金Supported by the National Basic Research Program of China(Nos.2007CB511903,2005CB523503)the International Cooperation Project of Ministry of Science and Technology of China(No.S2010GR0583)the National Natural Science Founda- tion of China(Nos.90709045,20805026)
文摘Metabolism of free fatty acids（FFAs） is related to several important physiological events and therefore their quantitaion in biological samples arouses extensive interest and efforts.Existing gas chromatography with flame ionization detector（GC-FID） methods for the analysis of FFAs normally require derivatization of them in order to lower boiling points.But this extra procedure tends to induce additional error and it is laborious and time-consuming.A derivatization-free method was therefore established in the present investigation to determine FFAs in human plasma by capillary（GC-FID）.After extraction of FFAs from plasma,a highly polar FFAP（free fatty acid in plasma） column was employed to directly quantitate FFAs concentration,free from derivatization reaction.All sample pretreatments were carried out at room temperature,improving recovery of short-chain FFAs.Heptadecanoic acid（C17：0） was employed as internal standard,and the proposed method was validated for recovery,precision,sensitivity,stabi-lity,and linearity.Validation data show that it is suitable for clinical study that has been applied to the evaluation of FFAs levels in plasma of diabetic nephropathy（DN） patients during the course of treatment.Forty-seven patients diagnosed with DN were admitted to the double-blind experiment.Control group（n=17） underwent solely basic treatment and the patients did not show significant change in FFAs concentration during six months of treatment.Experiment group（n=30） was supplied with traditional Chinese medicine besides basic treatment.After six months of medication,their plasma concentration of palmitic acid（C16：0）,stearic acid（C18：0） and oleic acid（C18：1n-9） decreased while linolenic acid（C18：3n-3） increased significantly（P〈0.05）.These four compounds could be served as biomar-kers in the evaluation of drug efficacy,and their quantitation in plasma may provide additional information for disease progression in DN patients.
基金supported by the Foundation of Shaanxi Provincial Science and Technology Plan Projects (2007K14-04)
文摘Objective To investigate the therapeutic effect of intensive glycemic control on patients with early diabetic nephropathy. Methods A total of 41 type 2 diabetes patients who developed microalbuminuria were divided into two groups randomly. Patients in Group A received intensive glycemic control and the blood glucose in Group B was regularly controlled. Glycemic monitoring and control were followed for 12 weeks to observe the changes of microalbuminuria in both groups; meanwhile the levels of serum lipids and coagulation indices were also recorded. Results The urine albumin excretion rate (UAER) in Group A decreased significantly from (47.91±13.86)mg/24h to (35.31±14.56)mg/24h after 12 weeks (P<0.05),and this decrease was significantly greater than that in Group B. However,Group B had no significant difference in UAER decrease [(48.93±13.32)mg/24h to (40.48±19.62)mg/24h,P>0.05]. The decrease of triglyceride (TG) and low-density lipoprotein cholesterol (LDL cholesterol),and the increase of high-density lipoprotein cholesterol (HDL cholesterol) showed no significant differences (P>0.05). And the level of plasma fibrinogen (FIB) showed no significant decrease after 12 weeks,either (P>0.05). Conclusion Intensive glycemic control reduces the level of microalbuminuria and may ameliorate the progression of early diabetic nephropathy.
文摘【目的】观察苦瓜皂苷G对糖尿病肾病(DN)大鼠的治疗作用及机制。【方法】从55只大鼠中随机抽取45只采用一次性腹腔注射链脲佐菌素(STZ)法诱导DN模型。将造模成功的38只大鼠随机分为模型组9只、苦瓜皂苷G低剂量组9只、苦瓜皂苷G中剂量组10只、苦瓜皂苷G高剂量组10只。剩余10只大鼠设为正常组。对应灌胃给药4周后,酶联免疫吸附分析(ELISA)检测大鼠24 h尿蛋白水平,血糖仪检测空腹血糖(FBG),全自动生化分析仪检测血肌酐(SCr)、血尿素氮(BUN)水平,苏木素-伊红染色(HE)法观察大鼠肾组织病理学变化,采用实时定量聚合酶链反应(RT-qPCR)和Western Blot法分别检测E-钙黏蛋白(E-cad)、α-平滑肌肌动蛋白(α-SMA)、Notch1、锌指蛋白转录因子1(Snail1)、Jagged1 m RNA及蛋白表达情况。【结果】与正常组比较,模型组24 h尿蛋白、FBG、血清SCr和BUN水平及肾组织α-SMA、Notch1、Snail1、Jagged1 mRNA及蛋白水平显著升高,肾组织E-cad m RNA及蛋白水平降低,肾组织可见肾小球萎缩、肾小管扩张及间质纤维化;与模型组比较,苦瓜皂苷G低、中、高剂量组24 h尿蛋白、FBG、血清SCr和BUN水平及肾组织α-SMA、Notch1、Snail1、Jagged1 mRNA及蛋白水平显著降低,肾组织E-cad m RNA及蛋白水平升高,肾组织病理损伤得到改善。【结论】苦瓜皂苷G可有效改善DN大鼠肾功能障碍、减轻肾脏纤维化,其机制可能与通过调控Notch/Snail1信号通路,抑制α-SMA和Jagged1 mRNA及蛋白表达,增强E-cad mRNA及蛋白表达有关。
